Clomipramine (303-49-1)

  • For any enquiries about this API or any of Tofigh Daru’s other products, please contact:
  • Contact Us >>

Product Detail

Mechanism:

Clomipramine, the 3-chloro analog of imipramine, is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, clomipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, clomipramine exerts a positive effect on mood. TCAs are potent inhibitors of the reuptake of serotonin and norepinephrine (chemical neurotransmitters in the brain that nerves use to communicate with one another). Therefore, TCAs enhance the actions of norepinephrine and serotonin by blocking their reuptake and prolonging their activity. Tertiary amine TCAs, such as clomipramine, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively.
Clomipramine is rapidly absorbed from the gastrointestinal tract and demethylated in the liver to its primary active metabolite, desmethylclomipramine.

Storage conditions: Preserve in well-closed containers. Store at controlled room temperature

Packaging: : polyethylene nylon plastic bag

CAS Number:  303-49-1

Formula: C19H23ClN2

Molecular Weight: 351.31 g/mol

Method of Analysis: Based on: BP

Application:

Clomipramine is a psychotropic agent used to treat obsessive-compulsive disorder (OCD), panic disorder, major depressive disorder, and chronic pain. Clomipramine may be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette’s disorder). Unlabeled indications include panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy, autistic disorder, trichotillomania, onchophagia, stuttering, premature ejaculation, and premenstrual syndrome. It may decrease the risk of suicide in those over the age of 65. Clomipramine shares structural similarities with a class of antidepressants known as tricyclic antidepressants (TCAs).